Excel Industries completes ₹40 Cr specialty chemicals capex project
Excel Industries Limited completed its ₹40 crore capital expenditure project for a dedicated specialty chemicals manufacturing setup on July 23, 2026. This facility supports a binding term sheet signed in November 2025 with an Indian specialty chemicals company for contract manufacturing and supply. The agreement is expected to yield an annual income of ₹35-40 crore, net of raw material costs, marking a key expansion in the company's specialty chemicals portfolio.
*this image is generated using AI for illustrative purposes only.
Excel Industries has completed its capital expenditure project for a dedicated specialty chemicals manufacturing setup on July 23, 2026. The company confirmed the completion of the facility, which was developed to fulfill obligations under a binding term sheet signed with an Indian specialty chemicals company. The agreement, initially disclosed in November 2025, involves the contract manufacturing and supply of specialty chemicals and is projected to generate an annual income of ₹35-40 crore, net of raw material costs.
The completion of this project marks a significant operational milestone for Excel Industries, enabling it to commence supplies under the aforementioned contract. The dedicated setup was commissioned at an estimated capital expenditure of approximately ₹40 crore. This investment aligns with the company’s strategy to expand its presence in the specialty chemicals segment through strategic partnerships and capacity enhancements.
Project Details
The following table outlines the key financial and operational parameters of the completed project as disclosed by the company:
| Parameter | Details |
|---|---|
| Project Completion Date | July 23, 2026 |
| Estimated Capital Expenditure | ~₹40 crore |
| Expected Annual Income (Net of Raw Material Cost) | ₹35-40 crore |
| Counterparty | Indian Specialty Chemicals Company |
| Nature of Agreement | Contract Manufacturing and Supply |
Regulatory Disclosure
The update was submitted pursuant to Regulation 30(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure serves as an update on a material event previously submitted by the company under Regulation 30 read with Schedule III Part A para B of the same regulations. The initial disclosure regarding the signing of the binding term sheet was made on November 12, 2025.
Surendra Singhvi, Company Secretary of Excel Industries Limited, digitally signed the disclosure on July 23, 2026. The submission was addressed to the Listing Departments of both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
What the Numbers Show
The projected annual income of ₹35-40 crore against a capital expenditure of ~₹40 crore suggests a rapid payback period for the dedicated setup. Generating net income nearly equivalent to the initial investment in the first year indicates strong unit economics for this specific contract manufacturing arrangement. This efficiency highlights the strategic value of the partnership and the specialized nature of the chemicals being produced, which likely command higher margins compared to standard commodity chemicals.
Historical Stock Returns for Excel Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.57% | +2.13% | -0.50% | -1.67% | -33.29% | -21.81% |
How will the commencement of this contract manufacturing agreement impact Excel Industries' overall revenue mix and margin profile in the upcoming fiscal year?
What are the specific terms regarding exclusivity or volume commitments in the binding term sheet with the Indian specialty chemicals partner?
Does this dedicated setup have excess capacity that could be leveraged for additional contracts, or is it fully allocated to this single counterparty?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
